Key result
COPD exacerbation hospitalization is linked to a ~3-fold increased risk of 4-week cardiovascular events.
Why the study?
Does hospitalization for exacerbated COPD increase the short-term risk of cardiovascular events in patients with COPD?
Case-Control (n=9,840)
Yes
Does hospitalization for exacerbated COPD increase the short-term risk of cardiovascular events in patients with COPD?
Answers are grounded in this paper and cite their sources.
Hospitalization for exacerbated COPD is associated with a significantly increased short-term risk of severe cardiovascular events, particularly NSTEMI and decompensated heart failure, highlighting the need for close cardiovascular monitoring post-exacerbation.
AIMS: Risk estimation of different types of cardiovascular events (CVEs) following a hospitalization for exacerbated chronic obstructive pulmonary disease (exCOPD) is warranted to consider prevention. METHODS AND RESULTS: A case-crossover study was conducted using the French exhaustive hospital discharge database (2013-19). Case-patients had a diagnosis of chronic obstructive pulmonary disease, were hospitalized for a CVE in France in 2018-19 (admission date was index date) with no other CVE in ≤12 months, and had ≥1 hospitalization for exCOPD ≤24 weeks before index CVE. The key exposure was hospitalization for exCOPD (overall and according to levels of care intensity) ≤1-4 weeks vs. 9-24 weeks preceding the CVE. Conditional logistic regression models estimated odds ratios (ORs) for the association between hospitalization for exCOPD and different types of CVE. Among 9840 case-patients, the most frequent CVE was decompensated heart failure (5888 case-patients, 59.8%). The CVE risk was greater ≤4 weeks after a hospitalization for any exCOPD [OR, 3.03; 95% confidence interval (CI), 2.90-3.16] and seven times greater if mechanical ventilation was necessary (OR, 6.99; 95% CI, 6.09-8.03). The risk of non-ST-elevation myocardial infarction (OR, 5.33; 95% CI, 4.47-6.34) was the highest among CVE. The risk was also significantly increased (P <0.05) for many other CVEs: ST-elevation myocardial infarction (OR, 4.24), resuscitated cardiac arrest (OR, 4.33), pulmonary embolism (OR, 4.02), atrial fibrillation/flutter (OR, 3.03), ischaemic stroke (OR, 1.93), and limb events (OR, 1.34). Ten percent of CVEs were fatal. CONCLUSION: Following hospitalization for exCOPD, the risk of cardiovascular complications is increased. These patients require close and sustained monitoring to mitigate CVE risk.
No takes yet. Share an insight, caveat, or question.
Zysman et al. (2025) conducted a case-control in Chronic obstructive pulmonary disease (COPD) (n=9,840). Hospitalization for exacerbated COPD ≤1-4 weeks preceding the cardiovascular event vs. Hospitalization for exacerbated COPD 9-24 weeks preceding the cardiovascular event was evaluated on Any cardiovascular event (OR 3.03, 95% CI 2.90-3.16). Hospitalization for exacerbated COPD was associated with a three-fold increased risk of cardiovascular events within 4 weeks (OR 3.03; 95% CI 2.90-3.16).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: